Response Monitoring of Metastatic Breast Cancer: A Retrospective Cohort Study Comparing CT and FDG-PET/CT

被引：0
|
作者：
Oltmann, Hjalte [1 ]
Alamdari, Tural [1 ]
Ljungstroem, Lasse [1 ]
Bulow, Jakob [1 ]
Vogsen, Marianne [2 ]
Gerke, Oke [1 ]
Hoilund-Carlsen, Poul Flemming [1 ]
Hildebrandt, Malene [1 ]
机构：
[1] Odense Univ Hosp, Dept Nucl Med, Odense, Denmark
[2] Odense Univ Hosp, Dept Oncol, Odense, Denmark
来源：
JOURNAL OF NUCLEAR MEDICINE | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1370
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic significance of FDG-PET/CT derived parameters in a first metastatic breast cancer relapse
    Depardon, E.
    Kanoun, S.
    Humbert, O.
    Riedinger, J.
    Tal, I.
    Vrigneaud, J.
    Lasserre, M.
    Toubeau, M.
    Berriolo-Riedinger, A.
    Dygai-Cochet, I.
    Fumoleau, P.
    Brunotte, F.
    Cochet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S76 - S77
  • [42] FDG PET/CT for monitoring response to neoadjuvant chemotherapy in breast cancer patients
    Katharina Dalus
    Gundula Rendl
    Lukas Rettenbacher
    Christian Pirich
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1992 - 1993
  • [43] Authors' Response: FDG-PET/ CT in Lung: Beyond Cancer
    Yamazaki, Motohiko
    Watanabe, Satoshi
    Tominaga, Masaki
    Yagi, Takuya
    Goto, Yukari
    Yanagimura, Naohiro
    Arita, Masashi
    Ohtsubo, Aya
    Tanaka, Tomohiro
    Nozaki, Koichiro
    Saida, Yu
    Kondo, Rie
    Kikuchi, Toshiaki
    Ishikawa, Hiroyuki
    ACADEMIC RADIOLOGY, 2025, 32 (02) : 1156 - 1156
  • [44] Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer?
    Andrade, W. P.
    Lima, E. N. P.
    Osorio, C. A. B. T.
    do Socorro Maciel, M.
    Baiocchi, G.
    Bitencourt, A. G. V.
    Fanelli, M. F.
    Damascena, A. S.
    Soares, F. A.
    EJSO, 2013, 39 (12): : 1358 - 1363
  • [45] Circulating tumor cells and FDG-PET/CT: biological and functional methods for therapeutic monitoring in metastatic breast
    Cristofanilli, M.
    De Giorgi, U.
    Rohren, E.
    Ueno, N. T.
    Miller, C.
    Doyle, G., V
    Jackson, S.
    Andreopoulou, E.
    Handy, B. C.
    Hortobagyi, G. N.
    Macapinlac, H. A.
    Fritsche, H. A.
    Valero, V.
    CANCER RESEARCH, 2009, 69 (02) : 362S - 362S
  • [46] Sarcoidosis Mimicking Metastatic Breast Cancer on FDG PET/CT
    Zivin, Sean
    David, Odile
    Lu, Yang
    INTERNAL MEDICINE, 2014, 53 (21) : 2555 - 2556
  • [47] Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET
    Sloof, Gerrit W.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2006, 20 (05) : 941 - 957
  • [48] Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer
    Kayani, Irfan
    Avril, Norbert
    Bomanji, Jamshed
    Chowdhury, Simon
    Rockall, Andrea
    Sahdev, Anju
    Nathan, Paul
    Wilson, Peter
    Shamash, Jonathan
    Sharpe, Kevin
    Lim, Louise
    Dickson, John
    Ell, Peter
    Reynolds, Andrew
    Powles, Thomas
    CLINICAL CANCER RESEARCH, 2011, 17 (18) : 6021 - 6028
  • [49] Clinical application of FDG-PET/CT in metastatic infections
    Kouijzer, Ilse J.
    Vos, Fidel J.
    Bleker-Rovers, Chantal P.
    Oyen, Wim J.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 61 (02): : 232 - 246
  • [50] FDG-PET/CT findings of a metastatic pituitary tumor
    Ilkhchoui, Yashar
    Appelbaum, Daniel E.
    Pu, Yonglin
    CANCER IMAGING, 2010, 10 (01): : 114 - 116
12345